Mesothelium expression of vascular cell adhesion molecule‐1 (VCAM‐1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC)

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer

• Publication date

  2017-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.30415PMID 28263384PMCID PMC5341143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

  2016cited by this paper
• Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.

  2016cited by this paper
• Role of aggressive surgical cytoreduction in advanced ovarian cancer

  2015cited by this paper
• Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.

  2015cited by this paper
• FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy

  2015cited by this paper
• Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.

  2015cited by this paper
• Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.

  2014cited by this paper
• Circulating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites

  2014cited by this paper
• Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer

  2014cited by this paper
• VCAM1 expression correlated with tumorigenesis and poor prognosis in high grade serous ovarian cancer.

  2013cited by this paper
• Imaging VCAM-1 as an Indicator of Treatment Efficacy in Metastatic Ovarian Cancer

  2013influential reference
• Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas

  2012cited by this paper
• Epithelial ovarian cancer.

  2012cited by this paper
• Prognostic significance of adhesion molecules (sICAM-1, sVCAM-1) and VEGF in colorectal cancer patients.

  2012cited by this paper
• Epithelial ovarian cancer.

  2011cited by this paper
• Neoadjuvant chemotherapy is the better treatment option in some patients with stage IIIc to IV ovarian cancer.

  2011cited by this paper
• Soluble VCAM-1 and its relation to disease progression in colorectal carcinoma

  2010cited by this paper
• Development of a multimarker assay for early detection of ovarian cancer.

  2010cited by this paper
• Plasma concentrations of VCAM‐1 and PAI‐1: A predictive biomarker for post‐operative recurrence in colorectal cancer

  2010cited by this paper
• Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.

  2010cited by this paper
• Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis.

  2009cited by this paper
• Vascular Cell Adhesion Molecule 1 Predicts Cancer-Free Survival in Clear Cell Renal Carcinoma Patients

  2006cited by this paper
• Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma.

  2003influential reference
• Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.

  2002cited by this paper
• Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma.

  2002cited by this paper
• Epithelial ovarian cancer.

  1999cited by this paper
• Soluble vascular cell adhesion molecule‐1 (sVCAM‐1) is an independent prognostic marker in Hodgkin's disease

  1998cited by this paper
• Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma.

  1998cited by this paper
• Serum levels of soluble vascular cell adhesion molecule‐1 (sVCAM‐1) are elevated in advanced stages of non‐Hodgkin's lymphomas

  1998cited by this paper
• Elevated serum levels of soluble vascular cell adhesion molecule‐1 (sVCAM‐1) closely reflect tumour burden in chronic B‐lymphocytic leukaemia

  1998cited by this paper
• Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer.

  1997cited by this paper

• Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements

  2025cites this paper
• VCAM-1 as a common biomarker in inflammatory bowel disease and colorectal cancer: unveiling the dual anti-inflammatory and anti-cancer capacities of anti-VCAM-1 therapies

  2025cites this paper
• Targeted regulatory strategies for VCAM-1 in multisystem diseases

  2025cites this paper
• Comparison of serum Vascular Cell Adhesion Molecule (VCAM) level among epithelial ovarian cancer patients and healthy women.

  2024cites this paper
• VCAM-1 complements CA-125 in detecting recurrent ovarian cancer

  2023cites this paper
• Cancer-mesothelial and cancer-macrophage interactions in the ovarian cancer microenvironment

  2023cites this paper
• Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)

  2022cites this paper
• The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer

  2022cites this paper
• Ectopic Tumor VCAM-1 Expression in Cancer Metastasis and Therapy Resistance

  2022cites this paper
• Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy

  2022cites this paper
• A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics

  2022cites this paper
• EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway

  2021cites this paper
• OTT_A_292259 1633..1641

  2021cites this paper
• Multiparameter MRI Radiomics Model Predicts Preoperative Peritoneal Carcinomatosis in Ovarian Cancer

  2021cites this paper
• CXC chemokine ligand‐13 promotes metastasis via CXCR5‐dependent signaling pathway in non‐small cell lung cancer

  2021cites this paper
• High VCAM-1 Predicts Poor Prognosis and is Associated with Chemotherapy Resistance in Nasopharyngeal Carcinoma

  2021cites this paper
• High preoperative serum sVCAM-1 concentration as a predictor of early ovarian cancer recurrence

  2020cites this paper
• Cancer-associated fibroblasts-derived VCAM1 induced by H. pylori infection facilitates tumor invasion in gastric cancer

  2020cites this paper
• A systematic literature review assessing if genetic biomarkers are predictors for platinum-based chemotherapy response in ovarian cancer patients

  2020cites this paper
• Apomorphine facilitates loss of respiratory chain activity in human epithelial ovarian cancer and inhibits angiogenesis in vivo.

  2020cites this paper
• Eukaryotic Initiation Factor 5A2 (EIF5A2) Contributes to Ovarian Tumor Growth and Metastasis

  2020cites this paper
• Theranostics in immuno-oncology using nanobody derivatives

  2019cites this paper
• A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy

  2019cites this paper
• Lentiviral CRISPR / Cas 9 nickase vector mediated BIRC 5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells

  2019cites this paper
• Ovarian Primary and Metastatic Tumors Suppressed by Survivin Knockout or a Novel Survivin Inhibitor

  2019cites this paper
• Fibrin Deposit on the Peritoneal Surface Serves as a Niche for Cancer Expansion in Carcinomatosis Patients

  2019cites this paper
• Relationship between vascular cell adhesion molecule-1 and morbidly adherent placenta.

  2018cites this paper
• long noncoding rna snhg15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer

  2018cites this paper
• Long Noncoding RNA CCAT2 Knockdown Suppresses Tumorous Progression by Sponging miR-424 in Epithelial Ovarian Cancer.

  2018cites this paper
• Long noncoding RNA SNHG15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer

  2018cites this paper
• Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells

  2018cites this paper
• Identification of potential prognostic TF‐associated lncRNAs for predicting survival in ovarian cancer

  2018cites this paper
• miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway

  2018cites this paper
• Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer

  2018cites this paper
• Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers

  2017influential citation
• Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells

  2017cites this paper
• Systemic bioinformatics analysis of recurrent aphthous stomatitis gene expression profiles

  2017cites this paper